Efavirenz but Not Atazanavir/Ritonavir Significantly Reduces Atovaquone Concentrations in HIV-Infected Subjects

Background. The current study was conducted to determine if efavirenz (EFV) or atazanavir/ritonavir (ATV/r)–based combination antiretroviral therapy (cART) impacted steady-state atovaquone plasma concentrations in human immunodeficiency virus (HIV)–infected patients receiving treatment doses of atov...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Infect Dis
Autors principals: Calderón, Mónica M., Penzak, Scott R., Pau, Alice K., Kumar, Parag, McManus, Maryellen, Alfaro, Raul M., Kovacs, Joseph A.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2016
Matèries:
HIV/AIDS
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4803107/
https://ncbi.nlm.nih.gov/pubmed/26797214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciw028
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars